SEARCH NEWS & VIEWS


Scientists Discover 'Outlier' Enzymes that Could Offer New Targets to Treat Diabetes, Inflammation
Perfecting a Viral Pack Mule
Facing an Opioid Epidemic
Team Awarded $3.4 Million to Develop Novel Treatments for Drug Addiction, Mood Disorders

NEWS & VIEWS HOME
PAST ISSUES
KUDOS
SCIENTIFIC CALENDAR
CA AUDITORIUM EVENTS
CONTACT




FOLLOW US
1
Scientists Discover 'Outlier' Enzymes that Could Offer New Targets to Treat Diabetes, Inflammation

The discovery from the Cravatt lab and colleagues is unusual because the enzymes do not resemble any known class of enzymes.

Perfecting a Viral Pack Mule

The study from the Reddy lab shows that new forms of a plant virus are useful in human therapeutics.

Facing an Opioid Epidemic

A personal story of a family affected by opioid addiction—and the research to help addicts quit for good.

Team Awarded $3.4 Million to Develop Novel Treatments for Drug Addiction, Mood Disorders

Professor Laura Bohn is principal investigator of the project.

  • New Findings in Humans Provide Encouraging Foundation for Upcoming AIDS Vaccine Clinical Trial
  • Scientists Identify Molecular Markers of Kidney Transplant Rejection
  • New Study Shows HIV Structure in Unprecedented Detail
  • Team Finds New Approach to Curbing Cancer Cell Growth
  • Scientists Find Clues to Neutralizing Coronaviruses Such as MERS
  • Researchers Discover New Ebola-Fighting Antibodies in Blood of Outbreak Survivor
  • Team Finds Popular Stem Cell Techniques Safe
  • Researchers Develop ‘LIGHTSABR’—A Cheap, Portable Drug-Discovery System
  • Study Reveals New Link Between Brain and Fat-Burning Circuit
  • Study Reveals Workings of Mysterious ‘Relief Valve’ that Protects Cells from Swelling
  • Philanthropist Samuel Yin Provides $12.8 Million Gift for New Scripps California Laboratories
  • Study Shows Path to ‘Dialing Down’ Autoimmunity without Compromising Immune Response
  • Scientists Solve 3D Structure of Protein that Guides the Immune System
  • Team Devises Powerful New Method for Modifying Drug Molecules
  • Flipping Molecular ‘Switch’ May Reduce Nicotine’s Effects in the Brain
  • Researchers Develop Versatile New Molecule-Building Technique